Godavari Drugs Limited (BOM:530317)

Godavari Drugs Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	43.8	55.49	37.86	52.45	41.28
Depreciation & Amortization	24.48	-	19.44	16.96	12.23
Other Operating Activities	38.45	66.48	31.94	25.73	28.98
Change in Accounts Receivable	171	-14.88	-23.56	-104.58	-91.03
Change in Inventory	-72.91	-7.95	-98.22	46.16	31.02
Change in Other Net Operating Assets	-92.85	85	164.72	75.57	-9.2
Operating Cash Flow	111.96	184.14	132.17	112.3	13.28
Operating Cash Flow Growth	-39.20%	39.32%	17.70%	745.75%	-78.73%
Capital Expenditures	-199.98	-132.01	-93.36	-52.45	-16.72
Sale of Property, Plant & Equipment	-	1.88	1.48	-	-
Other Investing Activities	4.86	-2.08	5.49	2.74	4.22
Investing Cash Flow	-195.12	-132.22	-86.39	-49.71	-12.5
Long-Term Debt Issued	127.28	-	1.65	-	33.26
Total Debt Issued	127.28	-	1.65	-	33.26
Long-Term Debt Repaid	-	-7.8	-	-27.08	-
Net Debt Issued (Repaid)	127.28	-7.8	1.65	-27.08	33.26
Other Financing Activities	-46.61	-48.74	-39.36	-29.13	-31.92
Financing Cash Flow	80.67	-56.54	-37.7	-56.21	1.34
Net Cash Flow	-2.5	-4.62	8.08	6.38	2.12
Free Cash Flow	-88.02	52.12	38.81	59.85	-3.44
Free Cash Flow Growth	-	34.30%	-35.15%	-	-
Free Cash Flow Margin	-7.71%	3.31%	2.43%	3.71%	-0.28%
Free Cash Flow Per Share	-11.70	6.92	5.16	7.95	-0.46
Cash Interest Paid	47.32	49.15	39.27	28.49	33.08
Cash Income Tax Paid	11.55	10.17	12.27	12.27	11.88
Levered Free Cash Flow	-72.71	-36.6	-336.51	67.61	-38.11
Unlevered Free Cash Flow	-43.14	-5.88	-311.97	85.42	-18.18
Change in Working Capital	5.24	62.17	42.94	17.15	-69.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.